FLGTHealthcareSmall-Cap
Fulgent Genetics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Fulgent Genetics, Inc. (FLGT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are FLGT insiders buying or selling?
Fulgent Genetics, Inc. insiders reported 4 open-market buys ($1.7M) and 125 sells ($31.1M) across 129 Form 4 filings — a net selling position of $29.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 3, 2026)
Total Form 4 filings
129
SEC EDGAR
Insider filers
5
Insider buys (4)
$1.7M
Insider sells (125)
$31.1M
Insider sentiment
Net sellingNet insider flow of $29.4M in net selling.
Recent FLGT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Hanlin Gao | Chief Scientific Officer | Sale | 1.7K | $19.66 | $32.9K |
| Sep 3, 2026 | Jian Xie | President and COO | Sale | 2.1K | $19.66 | $41.8K |
| Aug 28, 2026 | Jian Xie | President and COO | Sale | 1.2K | $19.91 | $23.7K |
| Aug 28, 2026 | Hanlin Gao | Chief Scientific Officer | Sale | 939 | $19.91 | $18.7K |
| Jun 3, 2026 | Jian Xie | President and COO | Sale | 2.1K | $17.89 | $38.4K |
| Jun 3, 2026 | Hanlin Gao | Chief Scientific Officer | Sale | 1.7K | $17.89 | $30.2K |
| May 28, 2026 | Jian Xie | President and COO | Sale | 1.2K | $17.60 | $21.1K |
| May 28, 2026 | Hanlin Gao | Chief Scientific Officer | Sale | 945 | $17.60 | $16.6K |
| Dec 3, 2025 | Jian Xie | President and COO | Sale | 1.1K | $28.33 | $32.3K |
| Dec 3, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 1.1K | $28.33 | $30.5K |
| Dec 2, 2025 | Jian Xie | President and COO | Sale | 1.2K | $29.57 | $35.4K |
| Dec 2, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 943 | $29.57 | $27.9K |
| Nov 25, 2025 | Jian Xie | President and COO | Sale | 681 | $30.47 | $20.8K |
| Nov 25, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 535 | $30.47 | $16.3K |
| Nov 21, 2025 | Jian Xie | President and COO | Sale | 10.0K | $29.10 | $291.0K |
| Sep 3, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 1.1K | $22.03 | $23.4K |
| Sep 3, 2025 | Jian Xie | President and COO | Sale | 1.1K | $22.03 | $24.8K |
| Aug 28, 2025 | Jian Xie | President and COO | Sale | 1.2K | $21.48 | $25.8K |
| Aug 28, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 943 | $21.48 | $20.3K |
| Aug 26, 2025 | Jian Xie | President and COO | Sale | 696 | $21.50 | $15.0K |
| Aug 26, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 548 | $21.50 | $11.8K |
| Jun 3, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 754 | $20.29 | $15.3K |
| Jun 3, 2025 | Jian Xie | President and COO | Sale | 1.1K | $20.29 | $23.0K |
| May 28, 2025 | Jian Xie | President and COO | Sale | 1.9K | $20.54 | $38.5K |
| May 28, 2025 | Hanlin Gao | Chief Scientific Officer | Sale | 1.0K | $20.54 | $21.3K |
Showing the 25 most recent of 129 Form 4 filings for Fulgent Genetics, Inc..
Most active FLGT insiders
- Jian Xie46 filings
- Paul Kim40 filings
- Hanlin Gao29 filings
- John C Bolger9 filings
- Ming Hsieh5 filings
Ask anything about FLGT insider activity
Use Trabud's AI agent to query Fulgent Genetics, Inc.'s Form 4 history in plain English — "Show me FLGT CEO purchases this year" or compare it against any other ticker.
Open the AI agentFLGT insider trading FAQ
Are Fulgent Genetics, Inc. insiders buying or selling?
Across 129 SEC Form 4 filings, Fulgent Genetics, Inc. (FLGT) insiders reported 4 open-market purchases totaling $1.7M and 125 sales totaling $31.1M. That is a net selling position of $29.4M.
How many insiders trade FLGT stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Fulgent Genetics, Inc.. The most recent filing was accepted on Sep 3, 2026.
Where does Trabud get FLGT insider trading data?
All FLGT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.